Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $101.7200 (3.45%) ($98.6100 - $102.0000) on Tue. Jun. 28, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.41% (three month average) | RSI | 28 | Latest Price | $101.7200(3.45%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -4.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(46%) XBI(44%) XLV(43%) VYM(38%) IWO(37%) | Factors Impacting UTHR price | UTHR will decline at least -1.205% in a week (0% probabilities). VIXM(-17%) TLT(-14%) UUP(-7%) IPO(-4%) BNDX(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.205% (StdDev 2.41%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
1 - 5 Day Possible Target | $91.83(-9.72%) | Resistance Level | $108.58 | 5 Day Moving Average | $102.16(-0.43%) | 10 Day Moving Average | $102.83(-1.08%) | 20 Day Moving Average | $108.58(-6.32%) | To recent high | -16% | To recent low | 3.4% | Market Cap | $4.512b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |